{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:30:22Z","timestamp":1788561022547,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jaci.2012.07.028","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T15:50:22Z","timestamp":1347551422000},"page":"103-109.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":176,"title":["Fel d 1\u2013derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A\u00a0randomized, placebo-controlled study"],"prefix":"10.1016","volume":"131","author":[{"given":"Deepen","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Couroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Salapatek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Laidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Larch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick P.","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.jaci.2012.07.028_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter","volume":"122","author":"Wallace","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.028_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1185\/030079903125003053","article-title":"Economic impact and quality-of-life burden of allergic rhinitis","volume":"20","author":"Schoenwetter","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaci.2012.07.028_bib3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2500\/aap.2008.29.3179","article-title":"The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in America survey","volume":"29","author":"Nathan","year":"2008","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2012.07.028_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaci.2005.05.017","article-title":"Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey","volume":"116","author":"Arbes","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.028_bib5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2007.07.056","article-title":"Asthma cases attributable to atopy: results from the Third National Health and Nutrition Examination Survey","volume":"120","author":"Arbes","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.028_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-3164.2010.00882.x","article-title":"Human allergy to environmental pet danders: a public health perspective","volume":"21","author":"Morris","year":"2010","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.jaci.2012.07.028_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nm1226","article-title":"Peptide-based therapeutic vaccines for allergic and autoimmune diseases","volume":"11","author":"Larch\u00e9","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2012.07.028_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaci.2010.11.029","article-title":"Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy","volume":"127","author":"Worm","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.028_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2222.2005.00099.x","article-title":"The role of allergen challenge chambers in the evaluation of anti-allergic medication: an international consensus paper","volume":"6","author":"Day","year":"2006","journal-title":"Clin Exp Allergy Rev"},{"issue":"suppl\u00a083","key":"10.1016\/j.jaci.2012.07.028_bib10","first-page":"118","article-title":"An environmental exposure chamber-specific rhinoconjunctivitis quality of life questionnaire: the symptoms of seasonal allergic rhinitis correlate with the quality of life of patients with ragweed allergy in the chamber","volume":"62","author":"Salapatek","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2012.07.028_bib11","unstructured":"Larch\u00e9 M, Patel D, Patel P, Salapatek AM, Laidler P, Hafner RP. Safety and efficacy of Fel d 1 derived peptide immunotherapy in a double-blind, placebo-controlled environmental exposure chamber (EEC) study. Available at: http:\/\/www.eaaci2012.com\/SiteSpecific\/Eaaci2012\/AbstractDetails.aspx?Nr=191. Accessed August 10, 2012."},{"issue":"suppl","key":"10.1016\/j.jaci.2012.07.028_bib12","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1067\/mai.2001.113672","article-title":"The role and remediation of animal allergens in allergic diseases","volume":"107","author":"Chapman","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.028_bib13","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.4049\/jimmunol.167.3.1734","article-title":"Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects","volume":"167","author":"Oldfield","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2012.07.028_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0140-6736(02)09332-7","article-title":"Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial","volume":"360","author":"Oldfield","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2012.07.028_bib15","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.20082901","article-title":"Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression","volume":"206","author":"Campbell","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2012.07.028_bib16","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1371\/journal.pmed.0020078","article-title":"T cell epitope immunotherapy induces a CD4(+) T cell population with regulatory activity","volume":"2","author":"Verhoef","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaci.2012.07.028_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","article-title":"Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis","volume":"118","author":"Dahl","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.028_bib18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jaci.2011.06.022","article-title":"Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis","volume":"128","author":"Didier","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.028_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2010.11.035","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults","volume":"127","author":"Nelson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.028_bib20","first-page":"A19","article-title":"The safety and clinical efficacy of Pollinex Quattro ragweed assessed in an environmental exposure chamber","volume":"98","author":"Patel","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2012.07.028_bib21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaci.2009.06.006","article-title":"Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber","volume":"124","author":"Horak","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.028_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1081-1206(10)61243-4","article-title":"Efficacy of fexofenadine in the prophylactic control of cat allergen-induced allergic rhinitis","volume":"96","author":"Berkowitz","year":"2006","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912012067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912012067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:38:14Z","timestamp":1758789494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674912012067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0091674912012067"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2012.07.028","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717958717.793462910","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717958717.793464421","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fel d 1\u2013derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A\u00a0randomized, placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2012.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}